Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy

Fecal Calprotectin Level Reflects the Severity ofClostridium difficileInfection

(2017) Jieun Kim et al.   Annals of Laboratory Medicine

The Influence of Proton Pump Inhibitors on the Fecal Microbiome of Infants with Gastroesophageal Reflux—A Prospective Longitudinal Interventional Study

(2017) Christoph Castellani et al.   Frontiers in Cellular and Infection Microbiology

Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis

(2016) Kousaku Kawashima et al.   BMC GASTROENTEROLOGY

Proton pump inhibitors and gastroenteritis

(2016) Robert-Jan Hassing et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis

(2016) Klaus Theede et al.   INFLAMMATORY BOWEL DISEASES

Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy

(2016) Ingunn Olafsdottir et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Proton pump inhibitors alter the composition of the gut microbiota

(2015) Matthew A Jackson et al.   GUT

Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis

(2015) Sayaka Yamaguchi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effect of oral diclofenac intake on faecal calprotectin

(2015) Zlatica Rendek et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Concentrations in Healthy Children Aged 1-18 Months

(2015) Feng Li et al.   PLoS One

Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders

(2014) Gian Paolo Caviglia et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma

(2014) Frank Serge Lehmann   WORLD JOURNAL OF GASTROENTEROLOGY

Evaluation of fecal calprotectin inCampylobacter concisusandCampylobacter jejuni/coligastroenteritis

(2013) Hans Linde Nielsen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Biomarkers in Diverticular Diseases of the Colon

(2012) Antonio Tursi   DIGESTIVE DISEASES

Calprotectin in ankylosing spondylitis – frequently elevated in feces, but normal in serum

(2012) Eva Klingberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Can chronic gastritis cause an increase in fecal calprotectin concentrations?

(2010) Massimo Montalto   WORLD JOURNAL OF GASTROENTEROLOGY

The Effect of Proton Pump Inhibitors on the Human Microbiota

(2009) B. Vesper et al.   CURRENT DRUG METABOLISM

Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications

(2009) Ramalinga R. Kedika et al.   DIGESTIVE DISEASES AND SCIENCES

Low-Dose Aspirin Affects the Small Bowel Mucosa: Results of a Pilot Study With a Multidimensional Assessment

(2008) Edgardo Smecuol et al.   Clinical Gastroenterology and Hepatology

Low-dose aspirin-induced gastrointestinal diseases: past, present, and future

(2008) Akiko Shiotani et al.   JOURNAL OF GASTROENTEROLOGY

Faecal blood loss with aspirin, nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors: systematic review of randomized trials using autologous chromium-labelled erythrocytes

(2008) R Andrew Moore et al.   ARTHRITIS RESEARCH & THERAPY